Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission
Authors:
- Hauts de France endocarditis study groupHGHauts de France endocarditis study group
- Hugues GeorgesHGHugues Georges
- Olivier LeroyOLOlivier Leroy
- Norair AirapetianNANorair Airapetian
- Nicolas LamblinNLNicolas Lamblin
- Elie ZogheibEZElie Zogheib
- Patrick DevosPDPatrick Devos
- Sebastien PreauSPSebastien Preau
Open Access
- 21 February 2018
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 1-8
Abstract
Right-sided infective endocarditis (RSIE) is an uncommon diagnosis accounting for less than 10% of cases of infective endocarditis. Optimal management for severely ill patients with RSIE remains challenging because few studies reported on management and outcome. The goal of our study was to determine outcome and associated prognostic factors in a population of ICU patients with a diagnosis of definite, active and severe RSIE. We performed a retrospective study in 10 French ICUs between January 2002 and December 2012. Main outcome was mortality at 30 days after ICU admission. Significant variables associated with 30-days mortality in the bivariate analysis were included in a logistic regression analysis. A total of 37 patients were studied. Mean age was 47.9 ± 18.4 years. Mean SAPS II, SOFA score and Charlson comorbidity index were 32.4 ± 17.4, 6.3 ± 4.4 and 3.1 ± 3.4, respectively. Causative pathogens, identified in 34 patients, were mainly staphylococci (n = 29). The source of endocarditis was a catheter related infection in 10 patients, intravenous drug abuse in 8 patients, cutaneous in 7 patients, urinary tract related in one patient and has an unknown origin in 7 patients. Vegetation size was higher than 20 mm for 14 patients. Valve tricuspid regurgitation was classified as severe in 11 patients. All patients received initial appropriate antimicrobial therapy. Aminoglycosides were delivered in combination with β-lactam antibiotics or vancomycin in 22 patients. Surgical procedure was performed in 14 patients. Eight patients (21.6%) died within 30 days following ICU admission. One independent prognostic factor was identified: use of aminoglycosides was associated with improved outcome (OR = 0.1; 95%CI = 0.0017–0.650; p = 0.007). Mortality of patients with RSIE needing ICU admission is high. Aminoglycosides used in combination with β-lactam or vancomycin could reduce 30 days mortality.Keywords
This publication has 34 references indexed in Scilit:
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is NephrotoxicClinical Infectious Diseases, 2009
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Endocarditis Caused by Staphylococcus aureusMedicine, 2009
- Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation sizeAmerican Heart Journal, 2005
- Infective EndocarditisCirculation, 2005
- Infective endocarditis at the tricuspid valve following central venous catheterizationJournal of Anesthesia, 2005
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- Tricuspid valve endocarditisAmerican Heart Journal, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987